According to Vanda Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $0.47. In 2022 the company made an earnings per share (EPS) of $0.21 a decrease over its 2021 EPS that were of $1.05.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $0.44 | 109.69% |
2022 | $0.21 | -80% |
2021 | $1.05 | 39.53% |
2020 | $0.75 | -80.18% |
2019 | $3.78 | 334% |
2018 | $0.87 | -247.06% |
2017 | -$0.59 | -19.05% |
2016 | -$0.73 | -55.32% |
2015 | -$1.64 | -347.37% |
2014 | $0.66 | -156.72% |
2013 | -$1.17 | -31.63% |
2012 | -$1.71 | 172.22% |
2011 | -$0.63 | -238.46% |
2010 | $0.45 | -119.7% |
2009 | -$2.30 | -31.61% |
2008 | -$3.36 | -31.32% |
2007 | -$4.90 | -99.27% |
2006 | -$675.54 | 36045.14% |
2005 | -$1.87 |